This trial will test if it is safe to use a patient's own cells to coat a plug to treat fistulizing Crohn's disease.
- Crohn's Disease
- Anal Fistulas
1 Primary · 2 Secondary · Reporting Duration: 2 months to approximately at 24 months
1 Treatment Group
1 of 1
5 Total Participants · 1 Treatment Group
Primary Treatment: MSC-AFP · No Placebo Group · Phase 1
Who is running the clinical trial?
Age 12 - 17 · All Participants · 9 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
How many participants have signed up for this clinical trial?
"Affirmative. According to clinicaltrials.gov, this trial is still seeking participants and was first made available on July 23rd 2018 . The study's most recent update was September 30th 2022, and 5 individuals are required for the project at a single site." - Anonymous Online Contributor
Has the FDA sanctioned MSC-AFP for public use?
"Taking into account the pre-existing data, our team at Power assigned a rating of 1 to MSC-AFP's safety level due it being in the first stage of clinical trials where we can only speculate on its efficacy." - Anonymous Online Contributor
Does this trial encompass those aged below 40?
"The trial is offered to patients aged 12 and 17, with 78 trials catering specifically to those under 18 years old and 279 for the senior population." - Anonymous Online Contributor
What are the criteria for inclusion in this research initiative?
"Aspiring participants in the clinical trial must have ileocolitis and be between 12 to 17 years old. The study is looking for approximately 5 individuals who meet these criteria." - Anonymous Online Contributor
Is this experiment still accepting new participants?
"Correct. According to clinicaltrials.gov, this research endeavour was first advertised on July 23 2018 and is currently seeking participants; the study needs 5 volunteers from one location." - Anonymous Online Contributor